BioFire’s New Multiplex PCR Testing Solution for Joint Infections

/
The BioFire Joint Infection Panel features a panel of 31 causative pathogens & 8 antimicrobial resistance markers most likely to cause joint infections.
For Labs

Matchup: The Stool Bench vs. the BioFire GI Panel

/
Stool culture is the standard for gastroenteritis testing, however, stool culture has several shortcomings, especially when compared to the BioFire GI Panel.

Tactics to De-escalate Transmission of COVID-19 in Healthcare Facilities

/
Like other commonly identified HAIs, the nosocomial transmission of the COVID-19 virus poses an immediate threat to patient health & safety.

Renal Complications in Sepsis Patients: The Importance of Timely Therapy

Sepsis-associated acute kidney injury (SA-AKI) is a potentially lethal complication of AKI. Timely diagnostics and antibiotic treatment are critical.

The Value of Syndromic Respiratory Testing for Outpatient Markets

/
Syndromic testing serves to allay any doubt when it comes to respiratory diagnostics so that clinicians can confidently make informed therapy decisions.

COVID PCR Testing Can be Fast—and It’s More Accurate than Rapid Antigen Tests

/
Rapid antigen tests provide results very quickly but can show a reduced sensitivity. Molecular PCR testing provides fast, accurate answers.

BioFire is now bioMérieux: One Company. One Future. Endless Possibilities.

/
The BioFire name has become the brand name for the bioMérieux Syndromic Testing product offering, with all the same products & panels you are used to. Learn more.

Why Nurses Should be Key Participants in ASPs

Nurses play a key position to impact antimicrobial stewardship efforts as they are antibiotic first responders. Learn more about nurses roles in ASPs.

C. difficile: the most common healthcare-associated infection

/
Clostridioides difficile can easily spread through healthcare settings, wreaking additional misery on those already ill. Learn more about this common HAI.

Cost Savings with Syndromic Meningitis/Encephalitis Testing from BioFire

/
Investing in syndromic meningitis/encephalitis testing from BioFire can provide many benefits over time, including significant cost savings.

Vote for the Best Clinical Product of 2020 in the Scientists’ Choice Awards

We are delighted to announce that our BioFire® Respiratory 2.1 (RP2.1) Panel has been nominated in the Best New Clinical Product of 2020 category!

BioFire Syndromic Trends Website Updated with SARS-CoV-2 Data

The public-facing SyndromicTrends.com website now includes detection-rate information for the BioFire® Respiratory 2.1 Panel, including data for SARS-CoV-2!

What is Sepsis?

/
Sepsis is the result of a body’s extreme response to an infection & at least 1.7 million adults in the US develop sepsis every year. Learn more about sepsis.